---

Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Spectrum: Partisan Bill (Republican 17-0)

Status: (Introduced) 2025-01-23 - Referred to the House Committee on Energy and Commerce. [HB679 Detail]

Download: US_Congress-2025-HB679-Introduced.pdf

---